Skip to main content

Telehealth companies lobby to extend pandemic-era rules

By The Wall Street Journal  
   November 28, 2022

Health startups and medical associations are lobbying for permanent permission to prescribe controlled substances remotely, part of a broader debate over the future of telehealth services that boomed during the pandemic.

Full story

Get the latest on healthcare leadership in your inbox.